Drug Information

Drug General Information
Drug ID
D02RKG
Former ID
DNCL002730
Drug Name
MORAb-004
Indication Colorectal cancer; Melanoma; Sarcoma [ICD9: 153, 154, 172, 202.8; ICD10:C18-C21, C43, C81-C86] Phase 2 [523863]
Company
Eisai
Target and Pathway
Target(s) Endosialin Target Info Modulator [533029]
References
Ref 523863ClinicalTrials.gov (NCT01574716) Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation. (SOURCE). U.S. National Institutes of Health.
Ref 533029A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors. Clin Cancer Res. 2015 Mar 15;21(6):1281-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.